These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15727003)
21. Mind the Gap! How the Digital Turn Upsets Intellectual Property. Vică C; Socaciu EM Sci Eng Ethics; 2019 Feb; 25(1):247-264. PubMed ID: 29079912 [TBL] [Abstract][Full Text] [Related]
22. Does the pharmaceutical sector have a coresponsibility for the human right to health? Schroeder D Camb Q Healthc Ethics; 2011 Apr; 20(2):298-308. PubMed ID: 21435305 [No Abstract] [Full Text] [Related]
23. DNA patents and human dignity. Resnik DB J Law Med Ethics; 2001; 29(2):152-65. PubMed ID: 11508191 [No Abstract] [Full Text] [Related]
24. Fair drug prices and the patent system. Resnik DB Health Care Anal; 2004 Jun; 12(2):91-115. PubMed ID: 15487813 [TBL] [Abstract][Full Text] [Related]
25. WARF's stem cell patents and tensions between public and private sector approaches to research. Golden JM J Law Med Ethics; 2010; 38(2):314-31. PubMed ID: 20579254 [TBL] [Abstract][Full Text] [Related]
26. The Idea of Patents vs. the Idea of University. de Campos TC New Bioeth; 2015; 21(2):164-76. PubMed ID: 27124964 [TBL] [Abstract][Full Text] [Related]
27. Access to medicines and the rhetoric of responsibility. Barry C; Raworth K Ethics Int Aff; 2002; 16(2):57-70. PubMed ID: 15709279 [No Abstract] [Full Text] [Related]
28. The morality of biotech patents: differing legal obligations in Europe? Ford R Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738 [No Abstract] [Full Text] [Related]
29. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration. Xu Z; Chen W Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085 [TBL] [Abstract][Full Text] [Related]
30. Patents and access to essential drugs. Loff B Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793 [TBL] [Abstract][Full Text] [Related]
31. Biodiversity, biopiracy and benefits: what allegations of biopiracy tell us about intellectual property. Hamilton C Dev World Bioeth; 2006 Dec; 6(3):158-73. PubMed ID: 17038007 [TBL] [Abstract][Full Text] [Related]
32. Some questions about the moral responsibilities of drug companies in developing countries. Brock DW Dev World Bioeth; 2001 May; 1(1):33-7. PubMed ID: 12870506 [No Abstract] [Full Text] [Related]
33. Impact of bioethics on patentability of inventions. Devaiah VH Indian J Med Ethics; 2010; 7(1):14-7. PubMed ID: 20166289 [TBL] [Abstract][Full Text] [Related]
34. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira MA; Bermudez JA; Chaves GC; Velásquez G Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916 [TBL] [Abstract][Full Text] [Related]
35. [Patents in pharmaceutical industry: between ethics and property rights]. Martínez Cárdenas EE Rev Salud Publica (Bogota); 2003; 5(1):18-23. PubMed ID: 14658364 [TBL] [Abstract][Full Text] [Related]
36. [Patentability of living material: public health concerns (1/2)]. Manuel C; Hairion D; Antoniotti S; Lafon C; Siméoni MC; Auquier P Presse Med; 2002 Oct; 31(34):1591-5. PubMed ID: 12426975 [TBL] [Abstract][Full Text] [Related]
38. Patents or patients? Global access to pharmaceuticals and social justice. de Wildt G; Khoon CC Med Confl Surviv; 2008; 24 Suppl 1():S52-61. PubMed ID: 18771195 [TBL] [Abstract][Full Text] [Related]
39. The ethics of intellectual property rights in biomedicine and biotechnology: an introduction. Górski A Sci Eng Ethics; 2005 Jan; 11(1):4-6. PubMed ID: 15726993 [No Abstract] [Full Text] [Related]